CIESC Journal ›› 2025, Vol. 76 ›› Issue (4): 1702-1710.DOI: 10.11949/0438-1157.20240965

• Biochemical engineering and technology • Previous Articles     Next Articles

Folate-modified pH-responsive copolymer mixed micelles for anticancer drug delivery

Haiqian ZHAO1(), Fang CHEN1, Tao CHEN1, Jianwei GUO1, Wenjing LIN1,2(), Chufen YANG1,2()   

  1. 1.School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, Guangdong, China
    2.Guangdong Provincial Laboratory of Chemistry and Fine Chemical Engineering Jieyang Center, Jieyang 515200, Guangdong, China
  • Received:2024-08-28 Revised:2024-11-12 Online:2025-05-12 Published:2025-04-25
  • Contact: Wenjing LIN, Chufen YANG

叶酸修饰的pH响应共聚物混合胶束用于抗癌药物递送

赵海钎1(), 陈方1, 陈涛1, 郭建维1, 林文静1,2(), 杨楚芬1,2()   

  1. 1.广东工业大学轻工化工学院,广东 广州 510006
    2.化学与精细化工广东省实验室揭阳分中心(广东省榕江实验室),广东 揭阳 515200
  • 通讯作者: 林文静,杨楚芬
  • 作者简介:赵海钎(2000—),男,硕士研究生,13640145955@163.com
  • 基金资助:
    国家自然科学基金项目(21676058);广东省自然科学基金项目(2024A1515011182);广州市科技计划项目(2023A04J0064)

Abstract:

Folate-modified pH-sensitive copolymer P1 (FA-PEG-PHEMA-PDEAEMA) was prepared by end-bromination, esterification, and atom transfer radical polymerization (ARGET ATRP) reaction. Copolymer P2 (PCL-PHEMA-PEGMA) was synthesized by ring-opening, bromination, and ATRP reactions. The structure, molecular weight, and molecular weight distribution of the copolymers were tested by 1H NMR, FTIR, and GPC. The CMC values of copolymers P1, P2, and mixed copolymer P1/P2 were 5.02, 1.58 and 2.51 mg/L, respectively, indicating that the copolymers could form stable micelles in solution. The drug-loaded micelles were prepared by dialysis method, and the morphology was spherical. The comprehensive drug loading performance and drug controlled release performance of mixed copolymer micelles MM were better than those of single copolymer micelles. Folate-modified drug-loaded micelles exhibited better inhibitory effects on HepG2 cells.

Key words: copolymer, mixed micelles, drug delivery, synthesis

摘要:

对聚乙二醇(PEG)进行末端溴化、酯化等聚合前改性,然后引发甲基丙烯酸-2-羟乙酯(HEMA)、甲基丙烯酸NN-二乙氨基乙酯(DEAEMA)进行原子转移自由基聚合(ATRP)反应合成含叶酸的pH响应共聚物P1(FA-PEG-PHEMA-PDEAEMA)。通过开环、溴化和ARGET ATRP反应合成共聚物聚己内酯-聚甲基丙烯酸-2-羟乙酯-聚甲基丙烯酸单甲氧基聚乙二醇酯P2(PCL-PHEMA-PEGMA)。通过1H NMR、FTIR和GPC表征了共聚物的结构、分子量及分子量分布。共聚物P1、P2和混合共聚物P1/P2的CMC值分别为5.02、1.58与2.51 mg/L,说明共聚物能够在溶液中形成稳定的胶束。通过透析法制备各载药胶束,形貌均呈球状,混合共聚物胶束MM综合载药性能和药物控制释放性能均优于单共聚物胶束。含叶酸载药胶束对HepG2细胞有更好的抑制作用。

关键词: 共聚物, 混合胶束, 药物递送, 合成

CLC Number: